Brief: Marksans Pharma Ltd June-Quarter Consol Net Profit 686.6 Million Rupees
11/08/2023 14:07
Aug 11 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARKSANS PHARMA LTD JUNE-QUARTER CONSOL NET PROFIT 686.6
MILLION RUPEES VERSUS 597.2 MILLION RUPEES
* MARKSANS PHARMA LTD JUNE-QUARTER CONSOL REVENUE FROM
OPERATIONS
5 BILLION RUPEES VERSUS 4.34 BILLION RUPEES
Source text for Eikon: ID:nBSE5zjTZf
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg